Monsanto rejects Bayer buyout, again

NEW YORK – Monsanto is rejecting the second takeover bid from Bayer.

The German drug and chemicals company last week boosted its offer from $62 billion, to about $65 billion, or $125 per share.

On Tuesday, Monsanto Co., a seed company, called revised offer inadequate, as it did the initial bid.

The St. Louis company said however that it remains open to talks with Bayer and others about a deal.